Increased homocysteine levels in polycystic ovary syndrome;Concentraciones elevadas de homocisteína en el síndrome de ovario poliquístico

Medicina Clinica

Volumn 129, Issue 8, 2007, Pages 292-294

  De La Calle, María ^a   Gallardo, Teresa ^a   Diestro, M Dolores ^a   Hernanz, Ángel ^a   Pérez, Elia ^a   Fernández Miranda, Consuelo ^b  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Abnormal fasting glucose; Folate; Homocysteine; Polycystic ovary syndrome

Indexed keywords

ANDROSTENEDIONE; CREATININE; CYANOCOBALAMIN; FOLLITROPIN; GLUCOSE; HOMOCYSTEINE; LIPID; LUTEINIZING HORMONE;

ADULT; AGE DISTRIBUTION; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FOLIC ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HIRSUTISM; HORMONE BLOOD LEVEL; HUMAN; LINEAR REGRESSION ANALYSIS; MENSTRUAL CYCLE; METABOLIC SYNDROME X; OVARY POLYCYSTIC DISEASE; SMOKING;

EID: 35348910829     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13109117     Document Type: Article

References (10)

1. Talbott EO, Zborowski JV, Rager JR, Boudreaux MY, Edmundowicz DA, Guzick DS. Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89:5454-61.
2. Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem. 2004;50:3-32.
3. Yarali H, Yildirir A, Aybar F, Kabakci G, Bukulmez O, Akgul E, et al. Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. Fertil Steril. 2001;76:511-6.
4. Wijeyaratne C, Nirantharakumar K, Balen A, Barth J, Sheriff R, Belchetz P. Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity? Clin Endocrinol. 2004;60:560-7.
5. Orio F Jr, Palomba S, Di Biase S, Colao A, Tauchmanova L, Savastano S. Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003; 88:673-9.
6. Expert Panel on detection Evaluation and Treatment of high Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
7. González-Gross M, Sola R, Castillo MJ. Folato: una vitamina en constante evolución. Med Clin (Barc). 2002;119:627-35.
8. Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, et al. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombosis diseases: guidelines and recommendations. Clin Chem Lab Med. 2003;41:1392-403.
9. Verhaar MC, Stroes E, Rabelink TJ. Folates and cardiovascular disease. Arterioscl Thromb Vasc Biol. 2002;22:6-13.
10. Carmina E. Metabolic syndrome in polycystic ovary syndrome. Minerva Gynecol. 2006;58: 109-14.